| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/29/2021 | Urovant Sciences Ltd. | UROV | Disposition | Stock Option (Right to Buy) | 70k | $6.88 | $481.6k | | 03/29/2021 |
| 03/29/2021 | Urovant Sciences Ltd. | UROV | Disposition | Stock Option (Right to Buy) | 3.8k | $13.65 | $51.2k | | 03/29/2021 |
| 03/29/2021 | Urovant Sciences Ltd. | UROV | Disposition | Stock Option (Right to Buy) | 133.5k | $3.64 | $485.9k | | 03/29/2021 |
| 03/29/2021 | Urovant Sciences Ltd. | UROV | Disposition | | 69k | $0.00 | $0 | | 03/29/2021 |
| 03/29/2021 | Urovant Sciences Ltd. | UROV | Disposition | Common Shares | 9.8k | $0.00 | $0 | | 03/29/2021 |
| 05/01/2020 | Urovant Sciences Ltd. | UROV | Grant | Common Shares | 44.3k | $0.00 | $0 | | 05/01/2020 |
| 01/07/2020 | Urovant Sciences Ltd. | UROV | Grant | Common Shares | 32.8k | $0.00 | $0 | | 01/07/2020 |
| 01/06/2019 | Urovant Sciences Ltd. | UROV | Grant | Stock Option (Right to Buy) | 70k | $6.88 | $481.6k | | 01/06/2019 |
| 10/15/2018 | Urovant Sciences Ltd. | UROV | Grant | Stock Option (Right to Buy) | 3.8k | $13.65 | $51.2k | | 10/15/2018 |
| 05/24/2017 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Stock Option (Right to Buy) | 52.5k | $5.50 | $288.8k | | 05/24/2017 |
| 05/10/2017 | Eledon Pharmaceuticals, Inc. | NVUS | Purchase | Common Stock | 10k | $9.99 | $100k | | 05/10/2017 |
| 05/15/2013 | AVANIR PHARMACEUTICALS, INC. | AVNR | Sale | Common Stock | 20k | $3.29 | $65.8k | | 05/15/2013 |
| 05/15/2013 | AVANIR PHARMACEUTICALS, INC. | AVNR | Sale | Common Stock | 57.7k | $3.28 | $189.4k | | 05/15/2013 |
| 05/15/2013 | AVANIR PHARMACEUTICALS, INC. | AVNR | Exercise | Stock Option (right to buy) | 4k | $0.88 | $3.5k | | 05/15/2013 |
| 05/15/2013 | AVANIR PHARMACEUTICALS, INC. | AVNR | Exercise | Stock Option (right to buy) | 15k | $0.88 | $13.2k | | 05/15/2013 |
| 05/15/2013 | AVANIR PHARMACEUTICALS, INC. | AVNR | Exercise | Stock Option (right to buy) | 38.7k | $0.88 | $34.1k | | 05/15/2013 |
| 12/02/2011 | AVANIR PHARMACEUTICALS, INC. | AVNR | Sale | Common Stock | 2.7k | $2.38 | $6.4k | | 12/02/2011 |
| 11/11/2011 | AVANIR PHARMACEUTICALS, INC. | AVNR | Sale | Common Stock | 92.2k | $2.62 | $242.1k | | 11/11/2011 |
| 11/11/2011 | AVANIR PHARMACEUTICALS, INC. | AVNR | Exercise | Stock option (right to buy) | 3.8k | $1.20 | $4.5k | | 11/11/2011 |
| 11/11/2011 | AVANIR PHARMACEUTICALS, INC. | AVNR | Exercise | Stock option (right to buy) | 12k | $0.88 | $10.6k | | 11/11/2011 |
| 11/11/2011 | AVANIR PHARMACEUTICALS, INC. | AVNR | Exercise | Stock option (right to buy) | 64.5k | $0.88 | $56.8k | | 11/11/2011 |
| 03/16/2010 | AVANIR PHARMACEUTICALS, INC. | AVNR | Sale | Common Stock | 4.2k | $2.08 | $8.8k | | 03/16/2010 |
| 03/16/2010 | AVANIR PHARMACEUTICALS, INC. | AVNR | Sale | Common Stock | 100 | $2.08 | $208 | | 03/16/2010 |
| 03/16/2010 | AVANIR PHARMACEUTICALS, INC. | AVNR | Sale | Common Stock | 11k | $2.08 | $22.9k | | 03/16/2010 |
| 03/16/2010 | AVANIR PHARMACEUTICALS, INC. | AVNR | Sale | Common Stock | 200 | $2.08 | $416.2 | | 03/16/2010 |